Innovations in Pharmaceutical Technology

Hot Topics

Tecan accelerates data-driven lab journey with agentic AI developments powered by NVIDIA

Tecan has announced the integration of Agentic artificial intelligence (AI) capabilities into its lab analytics platform Introspect, leveraging NVIDIA BioNeMo Agent Toolkit. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to optimise operations. Agentic AI will allow laboratories to move beyond traditional monitoring and reactive troubleshooting towards proactive actions that

15 July 2026

Product News - Spring 2026 Edition

IPT highlights some of the most recent exciting advancements in pharmaceutical manufacturing

12 April 2026

From passive polymers to active platforms: the nanotech evolution of hydrogels

Nanotechnology has unlocked a new generation of hydrogels that can be tuned for specific clinical demands. From degradation kinetics to drug release and mechanical resilience, nanoscale control is transforming hydrogels from passive wound dressings into active, minimally invasive platforms for joint restoration, tissue regeneration and targeted therapeutics

16 December 2025

Making sense of your scientific archive: how RAG helps biotechs do more with less

How is retrieval-augmented generation aiding smaller biotechs in collating and utilising disparate data systems?

16 December 2025

Semantic layering: the technology reshaping pharma data architecture

How is semantic layering technology addressing significant efficiency gaps, creating the infrastructure for more efficient manufacturing operations?

16 December 2025

Delivering precision at every stage: integrated API and sterile drug product services

SPOTLIGHT: How CARBOGEN AMCIS supports complex molecules and challenging formulations from early development to commercialisation

30 September 2025

Product Profile

Product News – Autumn Edition

IPT highlights some of the most recent exciting advancements in pharmaceutical manufacturing

Product Profile, 30 September 2025

Natoli Engineering Introduces EZ Level Feeder Base Leveling System

9 May 2025 -- Missouri, US -- Natoli Engineering, the global leader in tablet compression tooling, is unveiling the EZ Level Feeder Base Leveling System, Part Number SU 2970. This innovative design eliminates long setup times, enhances accuracy and minimizes formulation loss, and increases production time. You will no longer need to settle for “close enough” or “good enough” when using this solution that is built with precision in mind.

Product Profile, 8 May 2025

CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA

22 April 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce that its Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).

Product Profile, 21 April 2025

Central Research Laboratories: Single-Use Gamma Bags for Biopharma and Life Sciences Applications

25 March 2025 -- Minnesota, US -- Central Research Laboratories (CRL), a global leader in the remote-handling industry, is launching Single-Use Gamma Bags that have been designed to undergo gamma-sterilization procedures. CRL Single-Use Gamma Bags are an addition to the company’s Single-Use Beta Bag product line, which also includes the recently launched Single-Use Double Bags.

Product Profile, 25 March 2025

PR No2 enables quick and easy IR detection

A second edition of the LASER COMPONENTS Pyroelectric Receiver series is now available!

Product Profile, 11 March 2025

Press Releases

Concept Life Sciences Partners with OpenBench to Deliver Success-Based Drug Discovery Services

21 May 2026 -- Chapel-en-le-Frith, UK and California, US -- Concept Life Sciences, a leading global contract research organization with expertise in integrated drug discovery and development, and OpenBench, a pioneer of success-based AI hit discovery, today announced a strategic partnership to accelerate hit identification for biotech companies through a fee-for-success model.

Press Releases, 20 May 2026

Lonza & Oxford Nanopore Technologies Launch Direct RNA Sequencing Solution for GMP mRNA QC

20 May 2026 -- Basel, Switzerland, and Oxford, UK -- Oxford Nanopore Technologies, a company delivering a new generation of nanopore-based molecular sensing technology, and Lonza today announced the launch of a new technology approach designed to modernize and accelerate GMP quality control testing for mRNA therapeutics.

Press Releases, 19 May 2026

Safety Without Compromise: IKA Launches the Next Evolution of Magnetic Stirring

19 May 2026 -- Oxford, UK -- IKA’s new generation of magnetic stirrers incorporates state-of-the-art smart features, setting the new global standards for efficiency, safety, and reliability.

Press Releases, 18 May 2026

NGI Becomes First Certified Core Lab and Service Provider for Epigenica’s EpiFinder Platforms

19 May 2026 -- Stockholm, Sweden -- Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced an agreement with the National Genomics Infrastructure (NGI), one of the largest technical platforms at SciLifeLab.

Press Releases, 18 May 2026

Yourgene Health Launches Insight DPYD Assay

19 May 2026 -- Paris, France and Manchester, UK -- Yourgene Health, an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces the launch of Yourgene Insight DPYD assay, an assay utilising genetic insights for safer chemotherapy treatments to align with updated testing guidelines.

Press Releases, 18 May 2026

Digital

Getting AI right in drug discovery: why data quality is a scientific integrity issue

Every artificial intelligence-assisted conclusion that makes it outside the walls of an R&D organisation is a scientific claim that eventually has to stand on its own

Digital, 15 July 2026

Reinventing cell therapy manufacturing with microfluidics: from cure to care

As more and more cell therapies move from experimental treatments to commercial realities, manufacturing remains the primary bottleneck to patient access

Digital, 15 July 2026

How AI&ML are changing the landscape of pharma technology

From target identification and molecular design to process optimisation and quality control, artificial intelligence and machine learning are being positioned as transformative enablers across the pharma landscape. However, as adoption accelerates, it is becoming clear that the impact of these technologies is not determined solely by model sophistication or computational power. Rather, their effectiveness is fundamentally constrained by the availability, quality and structure

Digital, 12 April 2026

The digital symmetry of virtual pharma: architecting orchestration in an age of fragmentation

How are digital innovations offering a new way of working for contract development and manufacturing organisations?

Digital, 12 April 2026

From AI tools to AI ecosystems: why lab sciences companies are rethinking partnership models

How are deliberately structured artificial intelligence ecosystems integrating the tools scientists already rely on, enabling innovation while preserving provenance, governance and confidence across the drug discovery and development life cycle?

Digital, 12 April 2026

Manufacturing

The manufacturing executive’s new shield: closing the records liability gap

As regulators increasingly focus on individual accountability, can manufacturing leaders afford to treat data governance as a back-office function?

A new kind of blockbuster: could autonomous manufacturing transform pharma?

Will the next generation of blockbuster therapies be won by science alone or by the speed of manufacturing execution?

Scaling oligonucleotide manufacturing for the cardiometabolic era

A wave of small interfering RNA therapeutics targeting prevalent cardiometabolic diseases is anticipated to drive active pharmaceutical ingredients demand beyond the scale that existing manufacturing models were designed to support. Meeting this demand will require coordinated advances in manufacturing technology and supply chain structure alongside substantial investment in global production capacity

Integrated dissolution-absorption testing: a strategic imperative for establishing generic

In the fast-paced, competitive world of generics manufacturing, processes such as integrated dissolution-absorption testing can mean the difference between first to market and obscurity

Resilience in pharmaceutical manufacturing: what connected operations now require

Pharmaceutical manufacturers are rethinking operational resilience as connected systems, automation and infrastructure dependencies play a larger role in production. Continuity now depends on more than equipment performance. It also depends on how well companies coordinate technology, workforce oversight and compliance across increasingly integrated manufacturing environments

Advanced contamination detection systems in GMP manufacturing

Miriam Krechlok from Mettler-Toledo Product Inspection speaks to IPT about advanced contamination detection systems and how these are utilised in pharma manufacturing to ensure seamless and good manufacturing practice-compliant products

Communication breakdown: why soft skills are more important than ever in life sciences

How are life sciences organisations embracing new technologies to help develop soft skills, hopefully mitigating issues seen in the pharma manufacturing sector?

The future is gloveless

The future of aseptic pharmaceutical manufacturing is gloveless, but what might sound like a bold vision is already turning into reality today

Rethinking early phase development: how to move quickly without creating downstream risk

Early-phase development has always required urgency. Today, that urgency is shaped by a more complex set of pressures than ever before. Competitive intensity, milestone-driven financing structures and expanding regulatory expectations are redefining how biotech and virtual pharma companies approach the earliest stages of development.

Semantic layering: the technology reshaping pharma data architecture

How is semantic layering technology addressing significant efficiency gaps, creating the infrastructure for more efficient manufacturing operations?

Sustainable and scalable approaches to peptide manufacturing

Process innovations provide opportunities to reduce environmental impact while improving efficiency and product quality

X-ray CT for tablets: a powerful non-destructive tool for tablet characterisation

How is X-ray CT being used to ensure quality in tabletting?

Clone selection as a strategic lever: balancing speed, quality and long-term viability in CLD

In biologics development, clone selection is not just a technical milestone, it’s a strategic decision with far-reaching clinical and commercial implications. How can thoughtful clone selection – integrated with developability and manufacturability assessments – accelerate speed to clinic while safeguarding long-term success?

Advancing complex SM process development using biocatalysis

Biocatalysis is enhancing complex molecule process development. By merging the power of enzymes with chemical synthesis, scientists and manufacturers are addressing long-standing challenges in stereoselectivity, route complexity and sustainability

Delivering precision at every stage: integrated API and sterile drug product services

SPOTLIGHT: How CARBOGEN AMCIS supports complex molecules and challenging formulations from early development to commercialisation

Why advanced contamination detection systems are essential for pharmaceutical manufacturing

What are eight compelling reasons why manufacturers should prioritise the use of advanced contamination detection systems in their operations?

Lab Design

From variability to predictability: redefining visual inspection in high-mix pharma manufacturing

In high-mix environments, inspection systems must first be flexible – everything else builds on that foundation

Silence and noise: twin threats to scientific resilience in biopharma R&D

As workforce turnover reshapes the industry, how can organisations preserve the knowledge that drives scientific progress?

The rise of integrated, digital-first clinical lab systems: three key advances

What is the value of site-to-lab digitalisation, lab trial management systems, and end-to-end biobanking and specimen life cycle management in improving clinical labs?

Agentic AI systems in life sciences labs

Life sciences labs generate enormous volumes of equipment and environmental data, yet many teams still struggle to translate signals into timely, confident action. Agentic artificial intelligence systems can reason within context, prioritise what matters and recommend next steps, offering a shift from reactive alerting to operational decision support.

Drug discovery’s weakest link? Why synthesis is the critical bottleneck in the age of AI

How is artificial intelligence being utilised in labs to synthesise design and workloads?

Labs that think: how intelligent design is shaping the future of pharma R&D

How are emerging design principles like operational insight, molecular infrastructure and human-centred design reshaping safety, agility and performance across the life sciences landscape?

Advancing fluid management in labs with automated small-volume filling

How can the introduction of automation in fluid management systems improve biopharma manufacturing?

Designing for the next generation of pharma labs

How are modern pharma labs being designed with practicality and connectivity to ensure streamlined processes and happy staff?

Smarter labs, better discovery: how automation is evolving pharma R&D

How is the industry translating the potential of automated technologies into practical, flexible and scalable workflows that address the real-world challenges of modern laboratories, ensuring that innovation delivers measurable scientific and operational gains?

From legacy systems to sample automation: managing a successful transition to high-density cold samp

As the need for ultra-low temperature sample storage rises, many labs are stuck expanding outdated ‘freezer farms’ to meet demand. High-density automated cold storage offers a smarter, more efficient solution, but reaping the benefits depends on more than the technology itself – it requires thoughtful change management. How can companies approach change management to drive lasting adoption and maximise the value of automation?

Smart resource strategy: optimising lab assets in pharma

In an era of cost-conscious innovation, including tighter budgets, talent shortages and escalating regulatory demands, life sciences labs are under pressure to improve performance while managing budgets more wisely. By focusing on equipment utilisation and asset intelligence, labs can reduce downtime, avoid unnecessary purchases, optimise maintenance intervals and scale smarter – all without compromising quality or compliance

Robotic automation in the pharma lab

IPT talks to Roya Amini-Naieni at Trilobio about robotic automation in pharma research, the different applications of soft-and hardware, and how the field is likely to develop over the next five years

Automated labs: the future of drug R&D

IPT talks to David Fuller at Artificial Inc about how automated labs are revolutionising the pharma R&D space by connecting disparate systems, easing the burden of manual tasks on workers, and speeding up time-to-market with tools such as artificial intelligence

Rapid microbiological monitoring: transforming environmental monitoring in pharma manufacturing

Ensuring a manufacturing environment stays clear of bacteria and fungi is of utmost importance, especially when it comes to pharmaceuticals. How can this highly specialised monitoring be achieved in a fast, cost-effective manner?

One cannot leverage AI without a connected laboratory

A connected laboratory, where systems and devices communicate seamlessly, is the foundation to unlock AI’s full capabilities

The journey to full automation – for labs of all sizes

With the lab of the future becoming increasingly automated, how will this change workflows and how can the industry prepare for this?

Discovery and Development

From concept to clinic – partnering to scale up cell and gene therapies

How can the industry bridge the gap between cell and gene therapy innovation and reliable large-scale manufacturing?

Discovery and Development, 15 July 2026

How human tissue models could transform preclinical drug development

Animal testing in drug development is facing growing pressure as scientists and regulators adopt more human-relevant alternatives. Despite decades of reliance on animal studies, more than 90% of drugs that pass preclinical testing still fail in human trials. Advances in biotechnology, particularly human muscle models grown from real tissue, offer a promising alternative by more accurately mimicking human physiology

Discovery and Development, 15 July 2026

Starting material: the forgotten building block of CGT manufacturing

Donated human cells are the starting point for most cell and gene therapies. Before accepting a vial, bag or tissue sample, cell and gene therapy developers should ask three questions: is donor consent fit for purpose; was the right testing performed; and can chain of custody and chain of identity be reconstructed end to end?

Discovery and Development, 15 July 2026

Implementing iPSC-derived models in drug development workflows

As regulatory agencies encourage the adoption of new approach methodologies, pharmaceutical developers are increasingly exploring human induced pluripotent stem cell-derived models to improve translational predictivity. Successfully integrating these systems into drug development pipelines requires robust validation, a strong quality infrastructure and clear context-of-use frameworks

Discovery and Development, 15 July 2026

Fit-for-purpose measurement in drug development

Analytical measurement in drug development spans multiple attributes, from concentration and binding to quality, impurities and function. Aligning these measurements with workflow needs is critical for enabling timely and confident decision-making

Discovery and Development, 15 July 2026

Imaging and Sensing

De-risking gene therapy development through efficient stress testing of viral vectors

Could next-generation analytical technologies unlock faster, more informative stress testing for viral vectors?

Imaging & Sensing, 15 July 2026

Seeing what matters: how pH-responsive internalisation assays are reframing MoA in pharma

As targeted modalities proliferate, the ability to quantify ligand, antibody and receptor trafficking into acidic compartments at scale and in near real time is giving teams a far more direct read on drug activity. pH-responsive imaging and sensing approaches are unlocking higher throughput and more physiologically relevant internalisation readouts that bridge discovery, screening and translational workflows, helping to close the long-standing gap between beautiful microscopy

Imaging & Sensing, 12 April 2026

From mouse to medicine: the future of NIR-II FGS

As near-infrared imaging advances beyond the NIR-I window, a new generation of NIR-II fluorescent probes is redefining intraoperative visualisation. With improved tissue penetration, reduced scattering and enhanced signal-to-background ratios, these next-generation agents are expanding in vivo applications and opening new perspectives for precision surgery

Imaging & Sensing, 12 April 2026

How imaging flow cytometry is transforming cell and protein therapy

Advancements in imaging flow cytometry have improved the detection of particles in pharmaceutical formulations and helped provide insights into how these protein-based therapeutics work

Imaging & Sensing, 16 December 2025

Lessons learned from sequencing: a smart beginning for meaningful results

Massive sequencing, or next-generation sequencing, has opened the door to the fascinating world of genetics, and the secret on how to use this powerful tool most effectively hinges on the starting point: the sample

Imaging & Sensing, 30 September 2025

Transforming R&D workflows with automated super-resolution microscopy

What is super-resolution microscopy and how is it accelerating progress across the imaging sector?

Imaging & Sensing, 30 September 2025

Conferences and Events

EVENTS

Conferences and Events , 15 July 2026

Anglonordic Life Science Conference 2026

11 February 2026 -- London, UK -- Over 350 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, will get together in London on 23rd April, 2026 for the 22nd Annual Anglonordic Life Science Conference

Conferences and Events , 11 February 2026

BIO-Europe 2025

10 July 2025 -- Vienna, Austria -- BIO-Europe, Europe's premier biopharma partnering event, is heading to Vienna, Austria on November 3-5, 2025, followed by Digital Partnering on November 11-12.

Conferences and Events , 9 July 2025

Two Weeks to Go - LBS 2025 Spotlights Industry Pioneers, Disruptive Tech, Emerging Innovators

2 June 2025 — London, UK — In just two weeks, the second edition of the London Biotechnology Show (LBS) returns to ExCeL London on 18–19 June, bringing together one of the most influential gatherings in the global biotechnology calendar. The event promises cutting-edge science, transformative innovation, and forward-thinking leadership.

Conferences and Events , 1 June 2025

Attend Europe’s leading vaccine event!

World Vaccine Congress Europe will host 2500+ attendees, 280 speakers, 150 exhibitors and start-ups over the course of 4 days. With a multitude of tracks, the congress will cover everything vaccine related from start-to-finish from 13-16 October 2025.

Conferences and Events , 26 May 2025

IPT TV

Inside the 2024 American Biomanufacturing Summit

IPT TV, 3 June 2025

Visitor Registration at the London Biotechnology Show 2025 is Live!

Join the UK’s leading biotechnology event to explore groundbreaking biotech innovations, connect with global healthcare leaders, and discover the future of life sciences for 𝐅𝐑𝐄𝐄.

IPT TV, 21 April 2025

⭐We're proud to be a BioFIT 2024 partner!

Come and join us for the 13th edition of BioFIT, on December 3rd & 4th, 2024 in Lille and digital meetings days on December 11th & 12th, 2024!

IPT TV, 9 October 2024

LSX Nordic Congress 2024

Showcasing innovation, accelerating investment and facilitating partnering for life science leaders in Northern Europe.

IPT TV, 8 September 2024

TIDES Europe: Oligonucleotide & Peptide Therapeutics

Accelerate Your Therapeutics to Market: Expedite R&D, Improve CMC Efficiency & Build New Partnerships Join the industry’s leading event in Europe and access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market.

IPT TV, 4 September 2024